Venclexta and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Venclexta (venetoclax) and Brilinta (ticagrelor). Common drug interactions include bladder pain among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Venclexta and Brilinta. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

On Jul, 07, 2026

19 people who take Venclexta and Brilinta together, and have interactions are studied.

Venclexta and Brilinta drug interactions.

What are the common drug interactions of Venclexta and Brilinta, by gender? *:

female:

Bladder pain
Cardiac failure congestive
Cough
Drug hypersensitivity
Fatigue (feeling of tiredness)
Full blood count decreased
Hospitalisation
Neoplasm malignant (cancer tumour)
Pneumonia

male:

White blood cell count decreased
Dizziness
Decreased appetite
Dental caries
Dyspnoea (difficult or laboured respiration)
Escherichia infection (bacterial infection by escherichia coli)
Fatigue (feeling of tiredness)
Gingival pain (gum pain)
Mastication disorder (disease of chewing food)
Platelet count decreased

What are the common drug interactions of Venclexta and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood urine present
Dizziness
Hypotension (abnormally low blood pressure)

60+:

White blood cell count decreased
Asthenia (weakness)
Dental caries
Dyspnoea (difficult or laboured respiration)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Escherichia infection (bacterial infection by escherichia coli)
Fatigue (feeling of tiredness)
Gingival pain (gum pain)
Mastication disorder (disease of chewing food)
Platelet count decreased

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 8 people, 42.11%
Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 3 people, 15.79%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 15.79%
Acute Myeloid Leukaemia (In Remission): 2 people, 10.53%
Type 2 Diabetes: 1 person, 5.26%
Stress And Anxiety: 1 person, 5.26%
Pain: 1 person, 5.26%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.26%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 5.26%
High Blood Cholesterol: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Venclexta and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously